...
首页> 外文期刊>Blood purification >Effect of Increased Convection Volume by Mid-Dilution Hemodiafiltration on the Subclinical Chronic Inflammation in Maintenance Hemodialysis Patients
【24h】

Effect of Increased Convection Volume by Mid-Dilution Hemodiafiltration on the Subclinical Chronic Inflammation in Maintenance Hemodialysis Patients

机译:中稀血液血化对对流量增加对维持血液透析患者亚临床慢性炎症的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mid-dilution hemodiafiltration (MID) is a dialytic technique that might improve systemic inflammation of patients in chronic hemodialysis (HD) by increasing substitution volumes. To verify this hypothesis, we performed a prospective cross-over study comparing the effect on inflammatory biomarkers of higher convection by MID versus standard convection by post-dilution hemodiafiltration (HDF). Patients under chronic HD were therefore treated by MID and HDF by crossover design. Each treatment period lasted 4 months, with 1 month of wash-out where patients were treated by HD, for a total of 9 months. Primary outcome was the change of serum pre-dialytic C-Reactive Protein (CRP), interleukin 6 (IL-6), IL-1, IL-10, transforming growth factor-beta (TGF-beta), tumor necrosis factor-alpha, albumin and pre-albumin. Samples were obtained monthly. Ten HD patients were enrolled (age: 64.9 +/- 12.6 years; 70% males; dialytic vintage: 10.6 [2.7-16.2] years). Mean convection volume was 40.1 +/- 2.5 L/session in MID and 20.1 +/- 2.6 L/session in HDF. A significant reduction of beta 2-Microglobulin was detected as a result of either treatment. In MID, CRP decreased from 11.3 (3.2-31.0) to 3.1 (1.4-14.4) mg/L (p = 0.007), IL-6 from 12.7 (5.0-29.7) to 8.3 (4.41-4.0) pg/mL (p = 0.003), and TGF-beta from 10.6 (7.4-15.6) to 7.4 (5.9-9.3) ng/mL (p = 0.001). A significant reduction of CRP from 8.5 (3.2-31.0) to 4.6 (3.2-31.0) mg/L was also detected in HDF (p = 0.037), whereas no significant reduction of IL-6 (p = 0.147) and TGF-beta (p = 0.094) was found. Percentage reduction of IL-6 correlated with mean convective volume in HDF (R = 0.666; p = 0.036) and in MID (R = 0.760; p = 0.020). Therefore, MID and HDF are associated with an attenuation of inflammatory pattern that is correlated with a high convective volume. (c) 2018 S. Karger AG, Basel
机译:中稀释血液过滤(中间)是一种透析技术,可以通过增加取代体积来改善慢性血液透析(HD)患者的全身炎症。为了验证这一假设,我们进行了一项前瞻性的交叉研究,比较了稀释血液过滤(HDF)中期与标准对流对炎症生物标志物对炎症生物标志物的影响。因此,通过交叉设计通过中和HDF处理慢性HD下的患者。每次治疗期持续4个月,其中1个月的洗涤液,其中HD治疗患者,共9个月。主要结果是血清透析性C反应蛋白(CRP),白细胞介素6(IL-6),IL-1,IL-10的变化,转化生长因子-β(TGF-β),肿瘤坏死因子-α ,白蛋白和预白蛋白。每月获得样品。注册了十个高清患者(年龄:64.9 +/- 12.6岁; 70%的男性;透析复古:10.6 [2.7-16.2]年)。平均对比量为HDF中的40.1 +/- 2.5 L / 24.1 +/- 2.6 L /会话。由于任一治疗而检测到β2-微球蛋白的显着减少。中,CRP从11.3(3.2-31.0)降至3.1(1.4-14.4)mg / L(p = 0.007),IL-6,从12.7(5.0-29.7)至8.3(4.41-4.0)pg / ml(p = 0.003),TGF-β从10.6(7.4-15.6)至7.4(5.9-9.3)ng / ml(p = 0.001)。在HDF(P = 0.037)中也检测到8.5(3.2-31.0)至4.6(3.2-31.0)至4.6(3.2-31.0)mg / L的CRP的显着降低(P = 0.037),而IL-6没有显着降低(P = 0.147)和TGF-β发现(p = 0.094)。 IL-6的百分比与HDF中的平均对流体积相关(R = 0.666; p = 0.036)和中期(r = 0.760; p = 0.020)。因此,中和HDF与炎症模式的衰减相关,其与高对流体积相关。 (c)2018年S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号